6,267 Shares in Agilent Technologies, Inc. $A Purchased by First Citizens Bank & Trust Co.

First Citizens Bank & Trust Co. bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the third quarter, Holdings Channel reports. The firm bought 6,267 shares of the medical research company’s stock, valued at approximately $1,080,000.

A number of other institutional investors have also recently bought and sold shares of the business. Bank of New York Mellon Corp lifted its stake in shares of Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after purchasing an additional 2,440,360 shares during the period. Legal & General Group Plc bought a new position in shares of Agilent Technologies in the 2nd quarter worth $260,101,000. Bank of America Corp DE bought a new position in shares of Agilent Technologies in the 2nd quarter worth $213,269,000. Man Group plc acquired a new stake in shares of Agilent Technologies during the second quarter worth $179,257,000. Finally, Primecap Management Co. CA acquired a new stake in shares of Agilent Technologies during the second quarter worth $176,318,000.

Insider Activity at Agilent Technologies

In related news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the sale, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. This trade represents a 11.41% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Agilent Technologies Stock Up 0.9%

Shares of NYSE:A opened at $175.54 on Friday. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $177.05. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. The company has a market capitalization of $49.49 billion, a PE ratio of 28.71, a PEG ratio of 2.65 and a beta of 1.21. The company has a 50 day moving average price of $158.46 and a two-hundred day moving average price of $137.30.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period last year, the business posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts forecast that Agilent Technologies, Inc. will post 6.20 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be given a $0.2550 dividend. The ex-dividend date is Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. Agilent Technologies’s dividend payout ratio is currently 20.08%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on A shares. Barclays upped their price objective on Agilent Technologies from $175.00 to $195.00 and gave the company an “overweight” rating in a report on Wednesday, October 7th. Bank of America increased their target price on Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Weiss Ratings upgraded Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Citigroup boosted their target price on Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Finally, Royal Bank Of Canada boosted their target price on Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research report on Thursday, August 27th. Fifteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $173.65.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Analyst price-target support: Morgan Stanley forecast meaningful appreciation for Agilent shares, while TD Cowen raised its price target. The revisions reinforce positive Wall Street sentiment and suggest analysts see additional upside despite the stock’s recent gains. Morgan Stanley Forecasts Strong Price Appreciation for Agilent Technologies Stock Agilent Technologies Stock Gets Price Target Bump from TD Cowen
• Positive Sentiment: Proscia acquisition expands AI capabilities: Agilent agreed to acquire pathology-software company Proscia for $240 million upfront, with the total consideration potentially reaching $270 million through milestones. The deal would strengthen Agilent’s position in AI-enabled digital pathology and scientific intelligence, adding a potentially faster-growing software component to its tools and diagnostics portfolio. Agilent Technologies to Acquire Proscia
• Positive Sentiment: Favorable market backdrop: A new industry report projects the global metabolomics market will expand at a 17.3% compound annual growth rate through 2030. Agilent is identified as one of the companies positioned to benefit as laboratories adopt AI-assisted diagnostics and advanced analytical technologies. Global Metabolomics Market Report 2026
• Neutral Sentiment: China expansion: Agilent plans to expand its capabilities in China, which could improve access to regional demand and support longer-term growth. However, execution, regulatory and geopolitical risks remain considerations for investors. Agilent to Expand Capabilities in China
• Negative Sentiment: Acquisition costs and integration risk: The Proscia transaction requires substantial capital and may create integration and milestone-payment risks before it contributes materially to earnings. With Agilent already trading at a premium valuation, investors may scrutinize the deal’s execution and return on investment.

Agilent Technologies Profile

Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.

The company’s products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.